ELMD Stock Analysis
EL
Avoid
Based on Eyestock quantitative analysis, ELMD`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
High score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly overvalued
Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The company is headquartered in New Prague, Minnesota and currently employs 156 full-time employees. The company went IPO on 2010-08-13. The firm applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The company markets SmartVest Airway Clearance System (SmartVest System) which includes SmartVest SQL and SV2100 and related products, to patients with compromised pulmonary function. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe airway clearance therapy. The SmartVest SQL is smaller, quieter and lighter with programmability and ease of use. The company offers SmartVest SQL with SmartVest Connect wireless technology. The SmartVest Connect app allows patients and healthcare teams to track therapy in real-time and collaborate on care decisions to improve therapy adherence and patient outcomes. The company also offers single patient use (SPU) SmartVest and SmartVest Wrap to health care providers.